Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
Your view on FMCQF
Overview
What the company does, where it operates, and who runs it.
About Fresenius Medical Care AG & Co. KGaA
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Helen Giza
- Headquarters
- Else-KrOener Strasse 1, Bad Homburg, DE
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Helen Giza
- Headquarters
- Else-KrOener Strasse 1, Bad Homburg, DE
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally.
It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products.
In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services.
The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries.
Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Fresenius Medical Care AG & Co. KGaA, and the rating behind it. FMCQF last traded at $49.21, 11.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Fresenius Medical Care AG & Co. KGaA. Starting points for Fresenius Medical Care AG & Co. KGaA: P/E 11.6, EPS $3.49, beta 0.94 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Fresenius Medical Care AG & Co. KGaA. Trailing twelve-month EPS for Fresenius Medical Care AG & Co. KGaA stands at $3.49. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Fresenius Medical Care AG & Co. KGaA valued side by side against its closest peers. Fresenius Medical Care AG & Co. KGaA is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Fresenius Medical Care AG & Co. KGaA, and how their positions are changing. At a $14.26B market value, institutional positions materially move Fresenius Medical Care AG & Co. KGaA's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Fresenius Medical Care AG & Co. KGaA executives and directors. Shares of Fresenius Medical Care AG & Co. KGaA have traded between $44.71 and $61.84 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA is a $14.26B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Fresenius Medical Care AG & Co. KGaA. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Fresenius Medical Care AG & Co. KGaA. Coverage tracks Fresenius Medical Care AG & Co. KGaA within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.